QQQ   431.45 (-1.56%)
AAPL   172.70 (-2.18%)
MSFT   414.29 (-1.80%)
META   498.92 (-2.54%)
GOOGL   155.20 (-1.60%)
AMZN   183.60 (-1.36%)
TSLA   162.91 (-4.76%)
NVDA   866.64 (-1.73%)
AMD   160.40 (-1.76%)
NIO   3.86 (-6.08%)
BABA   70.41 (-1.23%)
T   16.23 (-0.49%)
F   12.25 (-2.85%)
MU   121.33 (-0.97%)
GE   153.23 (-0.91%)
CGC   7.03 (-9.87%)
DIS   113.05 (-0.84%)
AMC   2.53 (-4.53%)
PFE   25.89 (+0.12%)
PYPL   63.66 (-1.44%)
XOM   119.62 (-0.62%)
QQQ   431.45 (-1.56%)
AAPL   172.70 (-2.18%)
MSFT   414.29 (-1.80%)
META   498.92 (-2.54%)
GOOGL   155.20 (-1.60%)
AMZN   183.60 (-1.36%)
TSLA   162.91 (-4.76%)
NVDA   866.64 (-1.73%)
AMD   160.40 (-1.76%)
NIO   3.86 (-6.08%)
BABA   70.41 (-1.23%)
T   16.23 (-0.49%)
F   12.25 (-2.85%)
MU   121.33 (-0.97%)
GE   153.23 (-0.91%)
CGC   7.03 (-9.87%)
DIS   113.05 (-0.84%)
AMC   2.53 (-4.53%)
PFE   25.89 (+0.12%)
PYPL   63.66 (-1.44%)
XOM   119.62 (-0.62%)
QQQ   431.45 (-1.56%)
AAPL   172.70 (-2.18%)
MSFT   414.29 (-1.80%)
META   498.92 (-2.54%)
GOOGL   155.20 (-1.60%)
AMZN   183.60 (-1.36%)
TSLA   162.91 (-4.76%)
NVDA   866.64 (-1.73%)
AMD   160.40 (-1.76%)
NIO   3.86 (-6.08%)
BABA   70.41 (-1.23%)
T   16.23 (-0.49%)
F   12.25 (-2.85%)
MU   121.33 (-0.97%)
GE   153.23 (-0.91%)
CGC   7.03 (-9.87%)
DIS   113.05 (-0.84%)
AMC   2.53 (-4.53%)
PFE   25.89 (+0.12%)
PYPL   63.66 (-1.44%)
XOM   119.62 (-0.62%)
QQQ   431.45 (-1.56%)
AAPL   172.70 (-2.18%)
MSFT   414.29 (-1.80%)
META   498.92 (-2.54%)
GOOGL   155.20 (-1.60%)
AMZN   183.60 (-1.36%)
TSLA   162.91 (-4.76%)
NVDA   866.64 (-1.73%)
AMD   160.40 (-1.76%)
NIO   3.86 (-6.08%)
BABA   70.41 (-1.23%)
T   16.23 (-0.49%)
F   12.25 (-2.85%)
MU   121.33 (-0.97%)
GE   153.23 (-0.91%)
CGC   7.03 (-9.87%)
DIS   113.05 (-0.84%)
AMC   2.53 (-4.53%)
PFE   25.89 (+0.12%)
PYPL   63.66 (-1.44%)
XOM   119.62 (-0.62%)

Rani Therapeutics (RANI) Earnings Date, Estimates & Call Transcripts

$5.71
+0.31 (+5.74%)
(As of 02:27 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 8Estimated
Actual EPS
(Mar. 20)
-$0.27 Beat By $0.04
Consensus EPS
(Mar. 20)
-$0.31
Skip Charts & View Estimated and Actual Earnings Data

RANI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RANI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Rani Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.78)($0.78)($0.78)
Q2 20241($0.71)($0.71)($0.71)
Q3 20241($0.67)($0.67)($0.67)
Q4 20241($0.69)($0.69)($0.69)
FY 20244($2.85)($2.85)($2.85)

RANI Earnings Date and Information

Rani Therapeutics last released its quarterly earnings results on March 20th, 2024. The reported ($0.27) earnings per share for the quarter, topping analysts' consensus estimates of ($0.31) by $0.04. Rani Therapeutics has generated ($1.33) earnings per share over the last year (($1.33) diluted earnings per share). Earnings for Rani Therapeutics are expected to grow in the coming year, from ($0.94) to ($0.81) per share. Rani Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off prior year's report dates.

Rani Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/8/2024
Estimated)
------- 
3/20/2024Q4 2023($0.31)($0.27)+$0.04($0.27)--
11/8/2023Q3 2023($0.47)($0.36)+$0.11($0.36)--
8/11/2023Q2 2023($0.40)($0.37)+$0.03($0.37)--
5/10/2023Q1 2023($0.47)($0.33)+$0.14($0.33)--
3/22/2023Q4 2022($0.34)($0.35)($0.01)($0.35)$0.65 million-    
11/10/2022Q3 2022($0.33)($0.33)-($0.33)--
8/10/2022Q2 2022($0.28)($0.31)($0.03)($0.31)--
5/11/2022Q1 2022($1.00)($0.29)+$0.71($0.29)--
3/29/2022Q4 2021($1.28)($0.27)+$1.01($0.27)--    
11/15/2021Q3 2021($0.18)($0.16)+$0.02($0.16)--
9/12/2021Q2 2021($0.18)($0.12)+$0.06($0.12)$0.65 million$1.96 million

Rani Therapeutics Earnings - Frequently Asked Questions

When is Rani Therapeutics's earnings date?

Rani Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off last year's report dates. Learn more on RANI's earnings history.

Did Rani Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Rani Therapeutics (NASDAQ:RANI) reported ($0.27) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.04. Learn more on analysts' earnings estimate vs. RANI's actual earnings.

How much revenue does Rani Therapeutics generate each year?

Rani Therapeutics (NASDAQ:RANI) has a recorded annual revenue of $2.72 million.

How much profit does Rani Therapeutics generate each year?

Rani Therapeutics (NASDAQ:RANI) has a recorded net income of -$33.97 million. RANI has generated -$1.33 earnings per share over the last four quarters.

What is Rani Therapeutics's EPS forecast for next year?

Rani Therapeutics's earnings are expected to grow from ($0.94) per share to ($0.81) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:RANI) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners